HIT · Health In Tech, Inc. · Insider Trading

Represents restricted shares granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan upon his appointment as CEO ("Shares"). Such Shares vest in twelve equal monthly installments, commencing November 1, 2026, subject to continued service through the applicable vesting date.

Represents Shares which shall be automatically forfeited without consideration unless a performance-based acquisition milestone is achieved by December 31, 2028. Such Shares vest in full upon the closing of a qualifying acquisition, subject to continued service through such closing.

Represents Shares which shall be automatically forfeited without consideration unless a certain performance-based milestone (the "Milestone") is achieved by April 30, 2028 (the "Achievement Date"). Such Shares vest in twelve equal monthly installments, subject to continued service. If the Achievement Date falls before the 15th calendar day of the month, vesting commences on such 15th day, and if after, commences on the 1st day of the next calendar month.

Represents Shares which shall be automatically forfeited without consideration unless the Milestone is achieved by the Achievement Date. Such Shares vest in twelve equal monthly installments, subject to continued service. If the Achievement Date falls before the 15th calendar day of the month, vesting commences on such 15th day, and if after, commences on the 1st day of the next calendar month.

The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2026.

The reported price in Column 4 is a weighted average price. The reporting person undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price underlying the weighted average price disclosed in this footnote.

Represents restricted shares of Class A Common Stock surrendered to the Issuer to satisfy tax withholding and remittance obligations in connection with the vesting of restricted shares of Class A Common Stock for which service-based vesting requirements have been satisfied. The grant of such restricted stock was previously reported by the reporting person on a Form 4.

Includes 822,433 restricted shares of Class A Common Stock and 8,094,718 unrestricted shares of Class A Common Stock. Excludes 2,700,000 shares of Class B Common Stock and 711,510 options to purchase shares of Class A Common Stock.

Represents restricted shares of Class A Common Stock surrendered to the Issuer to satisfy tax withholding and remittance obligations in connection with the vesting of restricted shares of Class A Common Stock for which service-based vesting requirements have been satisfied. The grant of such restricted stock was previously reported by the reporting person on a Form 4.

Includes 616,113 restricted shares of Class A Common Stock and 22,535,185 unrestricted shares of Class A Common Stock. Excludes 9,000,000 shares of Class B Common Stock and 734,707 options to purchase shares of Class A Common Stock.

Represents restricted shares of Class A Common Stock surrendered to the Issuer to satisfy tax withholding and remittance obligations in connection with the vesting of restricted shares of Class A Common Stock for which service-based vesting requirements have been satisfied. The grant of such restricted stock was previously reported by the reporting person on a Form 4.

Includes 156,577 restricted shares of Class A Common Stock and 20,416 unrestricted shares of Class A Common Stock.

Represents restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. The shares of restricted stock vested as of their grant date.

Represents restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. The shares of restricted stock vested as of their grant date.

Represents restricted shares of Class A Common Stock surrendered to the Issuer to satisfy tax withholding and remittance obligations in connection with the vesting of restricted shares of Class A Common Stock for which service-based vesting requirements have been satisfied. The grant of such restricted stock was previously reported by the reporting person on a Form 4.

Includes 168,538 restricted shares of Class A Common Stock and 15,211 unrestricted shares of Class A Common Stock.

Represents restricted shares of Class A Common Stock surrendered to the Issuer to satisfy tax withholding and remittance obligations in connection with the vesting of restricted shares of Class A Common Stock for which service-based vesting requirements have been satisfied. The grant of such restricted stock was previously reported by the reporting person on a Form 4.

Includes 887,062 restricted shares of Class A Common Stock and 8,077,605 unrestricted shares of Class A Common Stock. Excludes 2,700,000 shares of Class B Common Stock and 711,510 options to purchase shares of Class A Common Stock.

Represents restricted shares of Class A Common Stock surrendered to the Issuer to satisfy tax withholding and remittance obligations in connection with the vesting of restricted shares of Class A Common Stock for which service-based vesting requirements have been satisfied. The grant of such restricted stock was previously reported by the reporting person on a Form 4.

Includes 755,592 restricted shares of Class A Common Stock and 22,515,434 unrestricted shares of Class A Common Stock. Excludes 9,000,000 shares of Class B Common Stock and 734,707 options to purchase shares of Class A Common Stock.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.8694 to $0.943 per share, inclusive. The reporting person undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2026.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.9103 to $0.9541 per share, inclusive. The reporting person undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Represents restricted shares of Class A Common Stock surrendered to the Issuer to satisfy tax withholding and remittance obligations in connection with the vesting of restricted shares of Class A Common Stock for which service-based vesting requirements have been satisfied. The grant of such restricted stock was previously reported by the reporting person on a Form 4.

Includes 938,743 restricted shares of Class A Common Stock and 8,059,649 unrestricted shares of Class A Common Stock. Excludes 2,700,000 shares of Class B Common Stock and 711,510 options to purchase shares of Class A Common Stock.

Represents restricted shares of Class A Common Stock surrendered to the Issuer to satisfy tax withholding and remittance obligations in connection with the vesting of restricted shares of Class A Common Stock for which service-based vesting requirements have been satisfied. The grant of such restricted stock was previously reported by the reporting person on a Form 4.

Includes 179,326 restricted shares of Class A Common Stock and 20,885 unrestricted shares of Class A Common Stock.

Represents restricted shares of Class A Common Stock surrendered to the Issuer to satisfy tax withholding and remittance obligations in connection with the vesting of restricted shares of Class A Common Stock for which service-based vesting requirements have been satisfied. The grant of such restricted stock was previously reported by the reporting person on a Form 4.

Includes 842,491 restricted shares of Class A Common Stock and 22,491,874 unrestricted shares of Class A Common Stock. Excludes 9,000,000 shares of Class B Common Stock and 734,707 options to purchase shares of Class A Common Stock.

Represents restricted shares of Class A Common Stock surrendered to the Issuer to satisfy tax withholding and remittance obligations in connection with the vesting of restricted shares of Class A Common Stock for which service-based vesting requirements have been satisfied. The grant of such restricted stock was previously reported by the reporting person on a Form 4.

Includes 984,340 restricted shares of Class A Common Stock and 8,042,235 unrestricted shares of Class A Common Stock. Excludes 2,700,000 shares of Class B Common Stock and 711,510 options to purchase shares of Class A Common Stock.

Represents restricted shares of Class A Common Stock surrendered to the Issuer to satisfy tax withholding and remittance obligations in connection with the vesting of restricted shares of Class A Common Stock for which service-based vesting requirements have been satisfied. The grant of such restricted stock was previously reported by the reporting person on a Form 4.

Includes 911,932 restricted shares of Class A Common Stock and 22,468,760 unrestricted shares of Class A Common Stock. Excludes 9,000,000 shares of Class B Common Stock and 734,707 options to purchase shares of Class A Common Stock.

Represents restricted shares of Class A Common Stock surrendered to the Issuer to satisfy tax withholding and remittance obligations in connection with the vesting of restricted shares of Class A Common Stock for which service-based vesting requirements have been satisfied. The grant of such restricted stock was previously reported by the reporting person on a Form 4.

Includes 189,249 restricted shares of Class A Common Stock and 14,969 unrestricted shares of Class A Common Stock.

Represents restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. The shares of restricted stock vested as of their grant date.

Represents restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. The shares of restricted stock vested as of their grant date.

Represents restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. The shares of restricted stock vested as of their grant date.

Represents restricted shares of Class A Common Stock surrendered to the Issuer to satisfy tax withholding and remittance obligations in connection with the vesting of restricted shares of Class A Common Stock for which service-based vesting requirements have been satisfied. The grant of such restricted stock was previously reported by the reporting person on a Form 4.

Includes 984,353 restricted shares of Class A Common Stock and 22,443,556 unrestricted shares of Class A Common Stock. Excludes 9,000,000 shares of Class B Common Stock and 734,707 options to purchase shares of Class A Common Stock.

Represents restricted shares of Class A Common Stock surrendered to the Issuer to satisfy tax withholding and remittance obligations in connection with the vesting of restricted shares of Class A Common Stock for which service-based vesting requirements have been satisfied. The grant of such restricted stock was previously reported by the reporting person on a Form 4.

Includes 1,030,065 restricted shares of Class A Common Stock and 8,025,235 unrestricted shares of Class A Common Stock. Excludes 2,700,000 shares of Class B Common Stock and 711,510 options to purchase shares of Class A Common Stock.

Represents restricted shares of Class A Common Stock surrendered to the Issuer to satisfy tax withholding and remittance obligations in connection with the vesting of restricted shares of Class A Common Stock for which service-based vesting requirements have been satisfied. The grant of such restricted stock was previously reported by the reporting person on a Form 4.

Includes 199,288 restricted shares of Class A Common Stock and 9,014 unrestricted shares of Class A Common Stock.

Represents restricted shares of Class A Common Stock granted pursuant to the Health In Tech Equity Incentive Plan which shall be automatically forfeited without consideration unless certain performance-based milestones are achieved. 20,000 shares shall vest in equal monthly installments over 12 months, commencing on or before July 1, 2026, if the first milestone is achieved by such date. The remaining 30,000 shares shall vest in equal monthly installments over 12 months, commencing on or before August 15, 2026, if the second milestone is achieved by such date.

Includes 78,985 unrestricted shares of Class A Common Stock and 64,554 restricted shares of Class A Common Stock. Excludes 165,085 options to purchase shares of Class A Common Stock.

Represents restricted shares of Class A Common Stock surrendered to the Issuer to satisfy tax withholding and remittance obligations in connection with the vesting of restricted shares of Class A Common Stock for which service-based vesting requirements have been satisfied. The grant of such restricted stock was previously reported by the reporting person on a Form 4.

Includes 1,060,738 restricted shares of Class A Common Stock and 8,023,013 unrestricted shares of Class A Common Stock. Excludes 2,700,000 shares of Class B Common Stock and 711,510 options to purchase shares of Class A Common Stock.

Represents restricted shares of Class A Common Stock surrendered to the Issuer to satisfy tax withholding and remittance obligations in connection with the vesting of restricted shares of Class A Common Stock for which service-based vesting requirements have been satisfied. The grant of such restricted stock was previously reported by the reporting person on a Form 4.

Includes 1,037,478 restricted shares of Class A Common Stock and 22,437,199 unrestricted shares of Class A Common Stock. Excludes 9,000,000 shares of Class B Common Stock and 734,707 options to purchase shares of Class A Common Stock.

Represents restricted shares of Class A Common Stock surrendered to the Issuer to satisfy tax withholding and remittance obligations in connection with the vesting of restricted shares of Class A Common Stock for which service-based vesting requirements have been satisfied. The grant of such restricted stock was previously reported by the reporting person on a Form 4.

Includes 205,680 restricted shares of Class A Common Stock and 6,667 unrestricted shares of Class A Common Stock.

Represents restricted shares of Class A Common Stock surrendered to the Issuer to satisfy tax withholding and remittance obligations in connection with the vesting of restricted shares of Class A Common Stock for which service-based vesting requirements have been satisfied. The grant of such restricted stock was previously reported by the reporting person on a Form 4 filed on January 8, 2026.

Includes 1,086,284 restricted shares of Class A Common Stock and 8,020,791 unrestricted shares of Class A Common Stock. Excludes 2,700,000 shares of Class B Common Stock and 711,510 options to purchase shares of Class A Common Stock.

Represents restricted shares of Class A Common Stock surrendered to the Issuer to satisfy tax withholding and remittance obligations in connection with the vesting of restricted shares of Class A Common Stock for which service-based vesting requirements have been satisfied. The grant of such restricted stock was previously reported by the reporting person on a Form 4 filed on January 8, 2026.

Includes 1,079,624 restricted shares of Class A Common Stock and 22,434,977 unrestricted shares of Class A Common Stock. Excludes 9,000,000 shares of Class B Common Stock and 734,707 options to purchase shares of Class A Common Stock.

Represents restricted shares of Class A Common Stock surrendered to the Issuer to satisfy tax withholding and remittance obligations in connection with the vesting of restricted shares of Class A Common Stock for which service-based vesting requirements have been satisfied. The grant of such restricted stock was previously reported by the reporting person on a Form 4 filed on January 8, 2026.

Includes 211,552 restricted shares of Class A Common Stock and 5,000 unrestricted shares of Class A Common Stock.

Represents restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. The restricted shares vest in equal monthly instalments over a twelve (12) month period, commencing on April 6, 2026, subject to the reporting person's continued service with the registrant through each applicable vesting date.

Represents restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. The shares of restricted stock vested as of their grant date.

Represents restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. The shares of restricted stock vested as of their grant date.

Represents restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. The shares of restricted stock vested as of their grant date.

Represents restricted shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan in connection with two proposed issuer transactions (each, a "Transaction"). Half of the shares vest in equal monthly installments over 12 months starting at the closing of the first Transaction ("First Transaction Shares"). The other half vest in equal monthly installments over 12 months starting at the closing of the second Transaction ("Second Transaction Shares"). Vesting is subject to continued service. If either Transaction does not close within 24 months after January 6, 2026 (the "Grant Date"), unvested shares relating to that Transaction will be automatically forfeited without consideration.

Includes 1,119,130 shares of restricted shares of Class A Common Stock and 8,009,425 unrestricted shares of Class A Common Stock. Excludes 2,700,000 shares of Class B Common Stock and 711,510 options to purchase shares of Class A Common Stock.

Represents restricted shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan in connection with two proposed issuer transactions (each, a "Transaction"). Half of the shares vest in equal monthly installments over 12 months starting at the closing of the first Transaction ("First Transaction Shares"). The other half vest in equal monthly installments over 12 months starting at the closing of the second Transaction ("Second Transaction Shares"). Vesting is subject to continued service. If either Transaction does not close within 24 months after January 6, 2026 (the "Grant Date"), unvested shares relating to that Transaction will be automatically forfeited without consideration.

Includes 220,000 shares of restricted shares of Class A Common Stock.

Represents restricted shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan in connection with two proposed issuer transactions (each, a "Transaction"). Half of the shares vest in equal monthly installments over 12 months starting at the closing of the first Transaction ("First Transaction Shares"). The other half vest in equal monthly installments over 12 months starting at the closing of the second Transaction ("Second Transaction Shares"). Vesting is subject to continued service. If either Transaction does not close within 24 months after January 6, 2026 (the "Grant Date"), unvested shares relating to that Transaction will be automatically forfeited without consideration.

Includes 1,126,130 shares of restricted shares of Class A Common Stock and 22,423,611 unrestricted shares of Class A Common Stock. Excludes 9,000,000 shares of Class B Common Stock and 734,707 options to purchase shares of Class A Common Stock.

Represent restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. The restricted shares vest in equal monthly instalments over a twelve (12) month period commencing on November 1, 2025, subject to the reporting person's continued service with the issuer through each applicable vesting date.

Represent restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. The shares of restricted stock vest quarterly commencing upon the date of grant, subject to the reporting person's continuous service through the vesting date.

Includes 5,730 shares of restricted stock and 100,315 shares of Class A Common Stock.

Represent restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. The shares of restricted stock vest quarterly commencing upon the date of grant, subject to the reporting person's continuous service through the vesting date.

Includes 5,730 shares of restricted stock and 63,005 shares of Class A Common Stock.

Represent restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. The shares of restricted stock vest quarterly commencing upon the date of grant, subject to the reporting person's continuous service through the vesting date.

Includes 5,730 shares of restricted stock and 100,315 shares of Class A Common Stock.

Represent restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan, which were subject to forfeiture on a pro-rata basis upon the issuer's annual stockholders meeting held on October 3, 2025.

Represent restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan, which were subject to forfeiture on a pro-rata basis upon the issuer's annual stockholders meeting held on October 3, 2025.

Represent restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan, which were subject to forfeiture on a pro-rata basis upon the issuer's annual stockholders meeting held on October 3, 2025.